Articles citing this paper
Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
Michael S. Gold A D , Jim Buttery B and Peter McIntyre C
+ Author Affiliations
- Author Affiliations
A Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, SA 5001, Australia.
B SAEFVIC, Department of General Medicine, Murdoch Children’s Research Institute, Royal Children’s Hospital Melbourne and Infectious Diseases Unit, Department of Paediatrics, Monash Children’s Hospital, Monash University, Melbourne, Parkville, Vic 3052, Australia.
C The National Centre for Immunisation Research, The Children’s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.
D Corresponding author. Email: michael.gold@adelaide.edu.au
Sexual Health 7(3) 320-324 https://doi.org/10.1071/SH09153
Submitted: 29 December 2009 Accepted: 23 March 2010 Published: 19 August 2010
16 articles found in Crossref database.
Safety of human papillomavirus vaccines: a review
Stillo Michela,
Carrillo Santisteve Paloma, Lopalco Pier Luigi
Expert Opinion on Drug Safety. 2015 14(5). p.697
Investigating safety profiles of human papillomavirus vaccine across group differences using VAERS data and MedDRA
Jia Yuxi,
Zhu Cong,
Du Jingcheng,
Xiang Yang,
Chen Yong,
Wang Wei, Tao Cui
PeerJ. 2019 7 p.e7490
Bug Breakfast in the Bulletin: The early impact of the National HPV Vaccination Program
Quinn Emma,
Donovan Basil, Sheppeard Vicky K.
New South Wales Public Health Bulletin. 2012 23(10). p.208
Medicines For Women (2015)
Answering human papillomavirus vaccine concerns; a matter of science and time
Hawkes David,
Lea Candice E, Berryman Matthew J
Infectious Agents and Cancer. 2013 8(1).
Adverse events following immunization in Ontario's female school-based HPV program
Harris Tara,
Williams Dawn M.,
Fediurek Jill,
Scott Tsui, Deeks Shelley L.
Vaccine. 2014 32(9). p.1061
Genetics of multiple sclerosis today
Sokolova E. A.,
Boyarskikh U. A.,
Aulchenko Yu. S., Filipenko M. L.
Biology Bulletin Reviews. 2016 6(2). p.113
Childhood vaccination associated adverse events by sex: A literature review
Weber Sandra Köhli, Schlagenhauf Patricia
Travel Medicine and Infectious Disease. 2014 12(5). p.459
Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine
Brotherton Julia M. L.,
Fairley Christopher K.,
Garland Suzanne M.,
Gertig Dorota, Saville Marion
Sexual Health. 2010 7(3). p.397
Value for money from HPV vaccination and cervical screening
Ashton Toni, Sopina Elizaveta
Human Vaccines & Immunotherapeutics. 2012 8(6). p.828
Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy
Brotherton Julia M. L.,
Kaldor John M., Garland Suzanne M.
Sexual Health. 2010 7(3). p.310
Safety of Human Papillomavirus Vaccines: A Review
Macartney Kristine K.,
Chiu Clayton,
Georgousakis Melina, Brotherton Julia M. L.
Drug Safety. 2013 36(6). p.393
Recent progress and concerns regarding the Japanese immunization program: Addressing the “vaccine gap”
Saitoh Akihiko, Okabe Nobuhiko
Vaccine. 2014 32(34). p.4253
Human papillomavirus vaccine in boys: background rates of potential adverse events
Clothier Hazel J,
Lee Katherine J,
Sundararajan Vijaya,
Buttery Jim P, Crawford Nigel W
Medical Journal of Australia. 2013 198(10). p.554
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus
Pellegrino Paolo,
Carnovale Carla,
Perrone Valentina,
Antoniazzi Stefania,
Pozzi Marco,
Clementi Emilio, Radice Sonia
European Journal of Epidemiology. 2013 28(8). p.705
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis
Mouchet Julie,
Salvo Francesco,
Raschi Emanuel,
Poluzzi Elisabetta,
Antonazzo Ippazio Cosimo,
De Ponti Fabrizio, Bégaud Bernard
Pharmacological Research. 2018 132 p.108
